Esaote Launches Updated S-Scan Open MRI System
The update of the S-scan magnetic resonance imaging (MRI) system reportedly offers an improved ergonomic design, algorithms to enhance image quality and reduced scan times.
Offering a variety of technological improvements to help facilitate optimal imaging and radiology workflows, Esaote has introduced the S-scan Open magnetic resonance imaging (MRI) system, an update to the company’s established S-scan MRI platform.
Esaote said the system’s combination of image acquisition and reconstruction capabilities through technologies such as SpeedUp and TR reduction enables clinicians to reduce artifacts, background noise and scan times. The combination of True-Motion technology with the S-scan Open MRI’s open magnet design allows one to capture real-time images of joint movements, according to Esaote.
The company adds that a complete set of RF coils, included with the S-scan Open MRI system, may facilitate improved spatial resolution, a high signal-to-noise ratio (SNR) and maximum sensitivity to anatomies being imaged.
Esaote added that key ergonomic features of the MRI system include a wide asymmetric rotating table, which promotes easy setup as well as maximum comfort and stability with patient positioning.
‘With S-scan Open, we have relied on Esaote’s latest technology in terms of the hardware and software platform. It has been specifically reengineered to face the challenging requirements of musculoskeletal exams,” said Massimo Olmi, the MRI marketing director of Esaote.
New MRI Research Explores Links Between Waist-to-Hip Ratio and Memory in Aging
March 13th 2025Researchers found that a higher waist-to-hip ratio in midlife was associated with higher mean diffusivity in 26 percent of total white matter tracts in the cingulum as well as the superior and inferior longitudinal fasciculus.
Meta-Analysis Shows No Difference Between bpMRI and mpMRI in Ruling Out csPCa
March 6th 2025In an 18-study meta-analysis involving over 4,600 patients, researchers found that bpMRI and mpMRI had equivalent pooled negative predictive value (NPV) of 92 percent for clinically significant prostate cancer (csPCa).
